Managers / Q1 2023 · view latest →
Tyrus Capital S.A.M.
CIK 0001543065 · 9 AVENUE J.F. KENNEDY, MONACO, O9, MC 98000 · 377 9999 5030
Summary
Tyrus Capital S.a.m. reported $17M in U.S.-listed holdings across 32 positions for Q1 2023.
The portfolio is heavily concentrated: AVIR alone accounts for 24.9% of reported value.
Compared with Q4 2022, the fund opened 9 new positions and exited 22.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Other · 74.6% · $13M
- Common Stock · 24.9% · $4M
- Equity WRT · 0.5% · $86,188
Quarter-over-Quarter Changes full breakdown →
vs Q4 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| MOTIVE CAPITAL CORP II | NEW | +92.4K | 92.4K | +$964,006 | $964,006 |
| JUPITER ACQUISITION CORP | NEW | +75.0K | 75.0K | +$757,500 | $757,500 |
| FORBION EUROPEAN ACQUSTN COR | NEW | +50.0K | 50.0K | +$527,000 | $527,000 |
| CRESCERA CAP ACQUISITION COR | NEW | +50.0K | 50.0K | +$523,000 | $523,000 |
| OCULIS HOLDING AG | NEW | +133.3K | 133.3K | +$54,899 | $54,899 |
| MOTIVE CAPITAL CORP II | NEW | +30.8K | 30.8K | +$4,832 | $4,832 |
| JUPITER ACQUISITION CORP | NEW | +37.5K | 37.5K | +$3,360 | $3,360 |
| FORBION EUROPEAN ACQUSTN COR | NEW | +16.7K | 16.7K | +$2,335 | $2,335 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2023
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | AVIRATEA PHARMACEUTICALS INChistory → | COM | 24.86% | $4M | 1.26M |
| 2 | GLOBAL PARTNER ACQISTN CORP | CL A SHS · *W EXP 01/14/202 | 12.26% | $2M | 233.3K |
| 3 | DHC ACQUISITION CORP | CLASS A ORD SHS · *W EXP 02/25/202 | 8.86% | $2M | 200.0K |
| 4 | ALTIMAR ACQUISITION CORP III | SHS CL A | 8.19% | $1M | 137.8K |
| 5 | TARGET GLOBAL ACQUISI I CORP | UNIT 99/99/9999 | 7.71% | $1M | 125.0K |
| 6 | L CATTERTON ASIA ACQUISITION | CLASS A ORD SHS · *W EXP 03/08/202 | 6.13% | $1M | 133.3K |
| 7 | MOTIVE CAPITAL CORP II | CL A ORD · *W EXP 99/99/999 | 5.71% | $968,838 | 123.2K |
| 8 | KERNEL GROUP HOLDINGS INC | CL A SHS · *W EXP 02/02/202 | 5.52% | $936,675 | 135.0K |
| 9 | JUPITER ACQUISITION CORP | CL A · *W EXP 08/17/202 | 4.48% | $760,860 | 112.5K |
| 10 | FORBION EUROPEAN ACQUSTN COR | CLASS A ORD SHS · *W EXP 12/10/202 | 3.12% | $529,335 | 66.7K |
| 11 | CRESCERA CAP ACQUISITION COR | CLASS A ORD SHS · *W EXP 11/18/202 | 3.09% | $525,191 | 75.0K |
| 12 | ARES ACQUISITION CORPORATION | COM CL A · *W EXP 02/02/202 | 3.09% | $524,800 | 60.0K |
| 13 | TWIN RIDGE CAPITAL ACQUIS CO | SHS CL A · *W EXP 03/07/202 | 3.02% | $513,415 | 66.7K |
| 14 | DISRUPTIVE ACQUISITION CORP | CLASS A ORD SHS · *W EXP 03/06/202 | 3.01% | $511,000 | 66.7K |
| 15 | RUMBWRUMBLE INC | *W EXP 09/16/202 | 0.37% | $62,975 | 27.5K |
| 16 | OCULIS HOLDING AG | *W EXP 03/06/202 | 0.32% | $54,899 | 133.3K |
| 17 | WALDENCAST PLC | *W EXP 07/27/202 | 0.12% | $20,000 | 33.3K |
| 18 | BZFDWBUZZFEED INC | *W EXP 12/03/202 | 0.10% | $16,667 | 166.7K |
| 19 | BBAI/WSBIGBEAR AI HLDGS INC | *W EXP 12/08/202 | 0.03% | $4,500 | 16.7K |
| 20 | PIIIWP3 HEALTH PARTNERS INC | *W EXP 11/19/202 | 0.01% | $2,046 | 25.5K |
| 21 | THUNDER BRIDGE CAP PRTNRS II | *W EXP 02/01/202 | 0.01% | $1,201 | 10.0K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2023 | $11M | 27 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $14M | 28 | Aug 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $17M | 32 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $46M | 45 | Feb 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $1M | 1 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $0 | 1 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $2M | 2 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.